Johnson & Johnson Was Ordered to Pay $572 Million for Its Role in the Opioid Crisis. With Similar Lawsuits Across the Country, That Could Be Just the Beginning
An Oklahoma judge ordered Johnson &Johnson to pay $572 million for its role in the opioid crisis in a historic ruling on Monday, marking the first time an opioid manufacturer has been deemed responsible in court and made to pay damages. It could have implications for the slew of lawsuits filed against opioid manufacturers and distributors throughout the country. A much bigger federal case before an Ohio judge involves at least 1,600 consolidated lawsuits from cities and counties from across the country, including hard-hit regions like Portsmouth, Ohio and Huntington, W.Va. The nationwide suit was filed in Ohio because of the state’s high opioid overdose rate, its proximity to various drugmakers’ headquarters and the judge’s experience on a previous consolidated case involving damage claims related to dyes used in magnetic resonance imaging procedures, according to the Associated Press. It is scheduled to go to trial in October. Another 400 cases are being fought over in state courts — many of them brought by state attorney generals. “Regardless of what happened in Oklahoma, the 1,600 cases pending in Ohio are racing towards a settlement. If anything, this trial might hasten the defendants to get the trial settled,” Abbe Gluck, a Yale law professor and Faculty Director of the Solomon Center for Health Law and Policy, tells TIME. The financial implications of the $572 million judgment against Johnson &Johnson could extend beyond Okla...
India has recorded nearly 87,000 new coronavirus infections as it edges closer to the United States in having the most cases in the world
New Zealand says it will ease its virus measures. Lockdowns return as Europe faces a second wave.
A missed diagnosis of COVID-19 in this 94-year-old who presented with delirium, low-grade fever, and abdominal pain resulted in spread among healthcare workers and other patients.Age and Ageing
Conclusion: The results of this review indicate that most osteopathic medical schools are at the early stages of EPA implementation, with emphasis varying by program year in terms of the specific EPAs addressed. Many schools appear engaged in curricular change efforts that will support the advancement of EPA use within their institutions. Faculty development was identified as a continued critical need for a majority of institutions. PMID: 32946547 [PubMed - as supplied by publisher]
Conclusion: Moderate quality evidence suggests that OMTh is effective for CNCP patients. There was a significant association between visceral OMTh and reduced pain severity and disability. More robust, high-quality randomized controlled trials with larger sample sizes are required to further explore the effectiveness of the OMTh in the management of CNCP. PMID: 32946545 [PubMed - as supplied by publisher]
A better understanding of the role of the intestinal microbiota in the development of chronic health issues in children could have important implications for prevention and treatment.Pediatric Nursing
Severe peanut allergies in children jump 85 per cent on Halloween and 60 per cent on Easter, and other nut allergies follow the same trend, possibly due to social gatherings where sweets are shared
CONCLUSIONS: While Olsen and Fenton both fit, the Olsen curves had overall best-fit for our sample of US NICU infants. The INTERGROWTH-21st curves fit the definitions for SGA and LGA for younger ages, but inferences outside of these definitions are unwarranted due to limited sample size. The INTERGROWTH-21st sample used for 33 weeks and older infants was physically smaller at the upper percentiles than our sample of US infants. PMID: 32945183 [PubMed - as supplied by publisher]
The expansion will create the region ’s largest hospital-based inpatient program for people struggling with alcohol and substance use problems.
Authors: Brignardello-Petersen R PMID: 32948289 [PubMed - as supplied by publisher]
More News: Addiction | Allergy | Cancer & Oncology | Chronic Pain | Emergency Medicine | Fentanyl | Health | Huntington's Disease | International Medicine & Public Health | Lawsuits | Legislation | Medicaid | Medical Law | MRI Scan | Overdose | Oxycodone | OxyContin | Pain | Pharmaceuticals | Smokers | Study | Substance Abuse | Substance Abuse Disorders | USA Health | Washington University | Websites | Yale